Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.

Newellis Inc

NUWE
1,16
0,00 (0,00%)
Pre Mercato
Ultimo aggiornamento: 09:53:18
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
11/3/202522:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
11/3/202515:00EDGAR2Form 8-K - Current report
11/3/202513:00GLOBENuwellis, Inc. Announces Fourth Quarter and Full Year 2024..
24/2/202522:05GLOBENuwellis Announces Retirement of Nestor Jaramillo, Jr. as..
20/2/202514:00GLOBEJACC: Heart Failure Paper Reports Promising Findings of..
18/2/202522:15GLOBENuwellis, Inc. To Report Fourth Quarter and Full Year 2024..
13/1/202514:00GLOBENuwellis Adds Nationally Ranked Utah Hospital as New..
19/12/202415:00GLOBENuwellis Regains Compliance with Nasdaq Listing Requirements
20/11/202419:29EDGAR2Form D - Notice of Exempt Offering of Securities
11/11/202414:00GLOBENuwellis, Inc. Announces Third Quarter 2024 Financial..
11/11/202412:04IHMARKETNEWSTesla Rises 5% Pre-Market After Surpassing $1T Market Value;..
05/11/202415:28GLOBENuwellis Announces Exercise of Warrants for $5.1 Million of..
04/11/202414:30GLOBENuwellis Receives Increased Reimbursement Rate for Aquadex..
01/11/202421:15GLOBENuwellis Announces Preliminary Results for Third Quarter of..
31/10/202413:00GLOBENuwellis Welcomes University of Iowa Health Care Stead..
23/10/202422:15GLOBENuwellis, Inc. To Report Third Quarter 2024 Financial..
25/9/202422:15GLOBENuwellis to Present at the Third Annual ROTH Healthcare..
30/8/202422:11EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
27/8/202415:00GLOBENew Study Published in Current Problems in Cardiology..
26/8/202422:45EDGAR2Form 8-K - Current report
24/8/202403:31EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/8/202415:00GLOBENuwellis Announces Pricing of $916,000 Registered Direct..
13/8/202423:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/8/202419:00EDGAR2Form 8-K - Current report
13/8/202414:00GLOBENuwellis, Inc. Announces Second Quarter 2024 Financial..
12/8/202415:15EDGAR2Form 8-K - Current report
08/8/202415:00GLOBENasdaq Panel Grants Nuwellis Continued Listing on the Nasdaq..
02/8/202422:12EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
26/7/202415:00GLOBENuwellis Announces First Pediatric Patient Treated in a..
25/7/202415:25EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
25/7/202414:31EDGAR2Form 8-K - Current report
24/7/202414:02GLOBENuwellis Announces Pricing of $2.0 Million Offering Priced..
23/7/202422:10GLOBENuwellis, Inc. To Report Second Quarter 2024 Financial..
17/7/202422:01EDGAR2Form 8-K/A - Current report: [Amend]
17/7/202415:12EDGAR2Form 8-K - Current report
17/7/202415:00GLOBENuwellis Marks First Commercial Sale of QUELIMMUNE™ Therapy..
12/7/202414:30GLOBESeaStar Medical Ships First QUELIMMUNE Product Order to U.S...
09/7/202415:00GLOBENew Evidence on Aquadex Ultrafiltration Therapy to be..
26/6/202414:45GLOBENuwellis Announces Reverse Stock Split
25/6/202415:00GLOBENuwellis Secures New Patent for Innovative Pediatric..
10/6/202422:15EDGAR2Form 8-K - Current report
06/6/202415:15EDGAR2Form 8-K - Current report
06/6/202415:00GLOBENuwellis and DaVita Extend Supply and Collaboration..
29/5/202417:54EDGAR2Form SD - Specialized disclosure report
17/5/202423:20EDGAR2Form DEFR14A - Revised definitive proxy soliciting materials
14/5/202415:00GLOBENuwellis Announces Expansion of Ultrafiltration Program to..
09/5/202415:00GLOBENuwellis Announces Purchase Agreement with a 50 Hospital..
08/5/202423:28EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/5/202423:26EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
07/5/202414:00GLOBENuwellis, Inc. Announces First Quarter 2024 Financial..
Apertura: Min: Max:
Chiusura: 1,16

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network